Tasmina Sheikh, MD
Psychiatry · Jupiter, FLNPI 1659376150
Payments from drug & device makers
Across 412 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$991
- Supernus Pharmaceuticals, Inc.$950
- Lundbeck LLC$508
- Sunovion Pharmaceuticals Inc.$501
- Teva Pharmaceuticals USA, Inc.$268
- plus $2K from 25 others
What the payments were for
- Food & beverage$6,65699%
- Education$841%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 89 | $1,198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 66 | $991 |
| Supernus Pharmaceuticals, Inc. | 61 | $950 |
| Lundbeck LLC | 32 | $508 |
| Sunovion Pharmaceuticals Inc. | 36 | $501 |
| Teva Pharmaceuticals USA, Inc. | 8 | $268 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $267 |
| Bausch Health US, LLC | 16 | $263 |
| Otsuka America Pharmaceutical, Inc. | 11 | $235 |
| Neurocrine Biosciences, Inc. | 10 | $213 |
| Johnson & Johnson | 8 | $157 |
| Livanova USA, Inc. | 3 | $151 |
| Merck | 6 | $105 |
| Vanda Pharmaceuticals Inc. | 5 | $102 |
| Idorsia Pharmaceuticals US Inc | 5 | $91 |
| Alkermes, Inc. | 5 | $84 |
| Shire North American Group Inc | 4 | $80 |
| Eisai Inc. | 5 | $75 |
| Jazz Pharmaceuticals Inc. | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $65 |
| Arbor Pharmaceuticals, Inc. | 4 | $56 |
| Almatica Pharma LLC | 3 | $55 |
| Ironshore Pharmaceuticals Inc. | 4 | $54 |
| Corium, LLC | 2 | $40 |
| Adlon Therapeutics L.p. | 2 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Boston Scientific | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $15 |
| TMS Neurohealth Centers Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,740 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AplenzinBupropion Hbr | 12 | $71,241 |
| Duloxetine Hcl | 42 | $1,864 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 34 | $968 |
| Bupropion XlBupropion Hcl | 31 | $783 |
| Buspirone Hcl | 30 | $539 |
| Hydroxyzine Hcl | 16 | $527 |
| Bupropion Hcl SrBupropion Hcl | 17 | $499 |
| Aripiprazole | 11 | $496 |
| Lamotrigine | 26 | $462 |
| Quetiapine Fumarate | 28 | $392 |
| Escitalopram Oxalate | 39 | $387 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 22 | $375 |
| Trazodone Hcl | 39 | $302 |
| Gabapentin | 28 | $282 |
| Zolpidem Tartrate | 17 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch Health US, LLCAplenzin | $263 | $71,24112 claims |
| Almatica Pharma LLCSertraline Hcl | $55 | $10826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Jupiter
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.